Targeting ECM–Integrin Interaction with Liposome-Encapsulated Small Interfering RNAs Inhibits the Growth of Human Prostate Cancer in a Bone Xenograft Imaging Model
Open Access
- 1 October 2005
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 12 (4) , 634-643
- https://doi.org/10.1016/j.ymthe.2005.05.012
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Intravenous RNA Interference Gene Therapy Targeting the Human Epidermal Growth Factor Receptor Prolongs Survival in Intracranial Brain CancerClinical Cancer Research, 2004
- Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cellsCancer Gene Therapy, 2003
- In Vivo Visualization of Metastatic Prostate Cancer and Quantitation of Disease Progression in Immunocompromised MiceCancer Biology & Therapy, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- A Pilot Trial of Vitaxin, A Humanized Anti-Vitronectin Receptor (antiαvβ3) Antibody in Patients with Metastatic CancerCancer Biotherapy & Radiopharmaceuticals, 2001
- Metastatic burden in nude mice organs measured using prostate tumor PC-3 cells expressing the luciferase gene as a quantifiable tumor cell markerThe Prostate, 2000
- Calcium signals in prostate cancer cells: specific activation by bone-matrix proteinsCell Calcium, 2000
- Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All αv IntegrinsCell, 1998
- Regression of Established Mouse Leukemia by GM-CSF-Transduced Tumor Vaccine: Implications for Cytotoxic T Lymphocyte Responses and Tumor BurdensHuman Gene Therapy, 1997
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994